GS-6620 Uses, Dosage, Side Effects and more
GS-6620 is under investigation in clinical trial NCT01316237 (A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection).
| Trade Name | GS-6620 |
| Generic | GS-6620 |
| Type | |
| Formula | C29H37N6O9P |
| Weight | Average: 644.622 Monoisotopic: 644.235963793 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
